Zhuhai Sailong Pharmaceutical Co Ltd (002898) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.062x

Based on the latest financial reports, Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a cash flow conversion efficiency ratio of -0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-28.66 Million ≈ $-4.19 Million USD) by net assets (CN¥460.47 Million ≈ $67.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhuhai Sailong Pharmaceutical Co Ltd (002898) balance sheet quality index to measure how much of total assets are equity-financed.

Zhuhai Sailong Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Zhuhai Sailong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhuhai Sailong Pharmaceutical Co Ltd (002898) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Zhuhai Sailong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhuhai Sailong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Encorp Bhd KLSE:6076	0.379x
Maming Enam Sembilan Mineral Tbk PT JK:AKSI	-0.008x
CWG Holdings Bhd KLSE:9423	0.098x
Mydas Real Estate Investments Ltd TA:MYDS	-0.209x
B.A.G Films and Media Limited NSE:BAGFILMS	-0.017x
ESSA Pharma Inc NASDAQ:EPIX	-0.039x
Redcastle Resources Ltd AU:RC1	-0.103x
Atlas Menkul Kiymetler Yatirim Ortakligi AS IS:ATLAS	0.034x

Annual Cash Flow Conversion Efficiency for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Zhuhai Sailong Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥384.15 Million ≈ $56.21 Million	CN¥19.06 Million ≈ $2.79 Million	0.050x	+163.74%
2024-12-31	CN¥499.28 Million ≈ $73.06 Million	CN¥-38.86 Million ≈ $-5.69 Million	-0.078x	-216.81%
2023-12-31	CN¥535.88 Million ≈ $78.42 Million	CN¥35.71 Million ≈ $5.23 Million	0.067x	+148.30%
2022-12-31	CN¥526.35 Million ≈ $77.02 Million	CN¥14.12 Million ≈ $2.07 Million	0.027x	-57.35%
2021-12-31	CN¥563.66 Million ≈ $82.48 Million	CN¥35.46 Million ≈ $5.19 Million	0.063x	+21040.16%
2020-12-31	CN¥587.00 Million ≈ $85.90 Million	CN¥174.69K ≈ $25.56K	0.000x	+100.42%
2019-12-31	CN¥659.02 Million ≈ $96.44 Million	CN¥-46.52 Million ≈ $-6.81 Million	-0.071x	-1507.08%
2018-12-31	CN¥663.54 Million ≈ $97.10 Million	CN¥3.33 Million ≈ $487.06K	0.005x	-96.35%
2017-12-31	CN¥618.64 Million ≈ $90.53 Million	CN¥85.13 Million ≈ $12.46 Million	0.138x	-55.48%
2016-12-31	CN¥254.45 Million ≈ $37.23 Million	CN¥78.65 Million ≈ $11.51 Million	0.309x	+38.92%
2015-12-31	CN¥213.20 Million ≈ $31.20 Million	CN¥47.44 Million ≈ $6.94 Million	0.223x	-39.11%
2014-12-31	CN¥140.55 Million ≈ $20.57 Million	CN¥51.36 Million ≈ $7.52 Million	0.365x	-36.90%
2013-12-31	CN¥111.97 Million ≈ $16.38 Million	CN¥64.84 Million ≈ $9.49 Million	0.579x	--

About Zhuhai Sailong Pharmaceutical Co Ltd

SHE:002898 China Biotechnology

Market Cap

$9.53 Million

CN¥65.12 Million CNY

Market Cap Rank

#27152 Global

#4746 in China

Share Price

CN¥0.37

Change (1 day)

-2.63%

52-Week Range

CN¥0.32 - CN¥16.81

All Time High

CN¥29.47